Learn More
BACKGROUND HER 2/new oncogene is an important prognostic marker in Breast Cancer and has implications in therapy planning. OBJECTIVE To describe the clinical features of HER 2/new positive and(More)
The aim of this study was to evaluate the S-phase fraction (SPF) of tumors in breast cancer patients in Pakistan. Its association with the traditional morphological prognostic markers, i.e., axillary(More)